FCA Venture Partners Announces Investment in eBlu Solutions

LOUISVILLE, KY – April 7, 2021 – eBlu Solutions announced today that it has raised an $11.4M Series A round led by OCA Ventures (Chicago), with co-investors Mutual Capital Partners (Cleveland) and FCA Venture Partners’ Health Innovations II (Winston-Salem/Nashville).

Under the leadership of CEO Mark Murphy, eBlu Solutions is a digital health prior authorization software company – whose digital platform streamlines the prior authorization of expensive infusion-based specialty medications.

Read More
KelseyCare Advantage announces new Medicare Advantage transportation benefit in partnership with SafeRide Health

KelseyCare Advantage announces a new Medicare Advantage transportation benefit through a strategic partnership with SafeRide Health, a non-emergency medical transportation technology and services leader dedicated to driving healthier lives. Through this new collaboration, KelseyCare Advantage is leading the way in Texas offering an innovative, technology-first benefit for Medicare Advantage enrollees looking for plans that make quality healthcare easier to obtain.

Read More
FCA Venture Partners Announces Investment in Integrative Health Centers

NASHVILLE, TN – February 3 2021 – Integrative Health Centers, Inc. (IHC), a leading provider of specialized health care services, announced today it has raised a $2.95 million Series Seed round, led by FCA Venture Partners’ Health Innovations fund, with participation from Martin Ventures and founder Ryan Chapman. The funds will be used to help fuel the company’s growth and expand its offerings to clinics and communities across the US.

Read More
Investment Thesis Report: Wearable Healthcare Technology

Wearable technology in healthcare has seen significant growth in demand, generating a booming market, and now insurers and other healthcare companies are discovering how supplying the new technology to their consumers and employees is beneficial. In 2019, the global wearable medical device market size was valued at approximately $13 billion and is expected to see a 27.9% CAGR through 2027

Read More